Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Waters Corporation    WAT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

WATERS CRP : Waters Introduces Highest Performing UPLC Ever Engineered – the new ACQUITY UPLC I-Class

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/02/2011 | 12:30pm CET
Waters Introduces Highest Performing UPLC Ever Engineered – the new ACQUITY UPLC I-Class
The New ACQUITY UPLC I-Class System Takes Separations Technology to the Next Level by Maximizing Peak Capacity and Extending the Performance of any MS Detector
Milford, Mass. - 2011-06-01

Waters Corporation (WAT:NYSE) today introduced the new Waters® ACQUITY UPLC® I-Class System, the highest performing UPLC® system ever engineered taking UltraPerformance LC® separations technology to the next level.  For scientists challenged by the most difficult separations, the ACQUITY UPLC I-Class features the lowest system dispersion and lowest carryover in the industry today. Low dispersion maximizes peak capacity thereby advancing chromatographic separations and optimizing the performance of any mass spectrometer.

“The scientific discoveries with the biggest potential to improve our lives often rely on samples and compounds that are the most difficult to understand. The ACQUITY UPLC I-Class System was designed specifically for the rapid pace of laboratories on the cutting edge of research,” said Art Caputo, President of the Waters Division. “Design and function of the I-Class are based on continuous customer input resulting in improvements in sub-two-micron separation that only the originator of the technology can exploit. Whether customers need to rapidly analyze sample-limited compounds amid a complex matrix or they seek to optimize the performance of any mass spectrometer on the market, ACQUITY UPLC I-Class enables scientists to solve their most complex separations and detection challenges.”

Keeping pace with today’s most advanced laboratories, the ACQUITY UPLC I-Class System excels when analyzing complex, sample-limited compounds.   Sample-limited compounds include high potency medications, trace levels of food or water contamination, and (advanced) sophisticated biotherapeutics.  These samples can represent complex separation challenges requiring an LC system that can maximize the benefits of sub-two-micron for faster throughput and optimized MS performance.

While there are many innovations built into the new ACQUITY UPLC I-Class, minimal system volume is a new key feature. Reduced system volume significantly decreases dispersion rates for reproducibly higher resolution and superior peak capacity. Reduced dispersion and small peak volumes extend the sensitivity of any mass spectrometer. Additionally, low dispersion footprint allows users to reduce their separation cycle times without impact to the separation as resolution is maintained even for ballistic gradients lasting less than one minute. Also importantly, new   design and materials dramatically reduce sample carryover effects, thus increasing user confidence in results.

The ACQUITY UPLC I-Class also features class leading flexibility and precise sampling capabilities. Depending on application needs, users can choose either the highest precision and lowest dispersion fixed-loop Sample Manager, or the world’s first low dispersion variable volume Sample Manager with a flow-through needle design, which delivers high-precision injections, excellent sample recovery, and lowest sample carryover optimizing the performance for even the most sensitive mass detectors.

ACQUITY UPLC family

Seven years ago, Waters pioneered a new category of chromatographic performance with the commercialization of sub-2-

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WATERS CORPORATION
02/24 WATERS CORP /DE/ : Management's Discussion and Analysis of Financial Condition a..
02/24 WATERS : New Chromatography Study Results from Waters Corporation Described (Sca..
02/14 WATERS CORPORATION : Announces 2017 Investor Day and Webcast
02/02 WATERS : Reports Fourth Quarter and Full Year 2016 Financial Results
02/02 WATERS : Gavekal Capital Boosts Position by $11,028,611 in Waters Corporation
01/25 WATERS CORPORATION (NYSE : WAT) Files An 8-K Results of Operations and Financial..
01/24 WATERS : beats Street 4Q forecasts
01/24 WATERS CORP /DE/ : Results of Operations and Financial Condition, Financial Stat..
01/24 WATERS : Reports Fourth Quarter and Full Year 2016 Financial Results
01/23 S&P 500 MOVERS : Qcom, wat
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
02/20 METTLER-TOLEDO : Trying To Determine An Entry Point
02/14 Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q4 2016 Update
01/27 Make Money Using Analyst Ratings
01/24 Waters' (WAT) CEO Christopher O'Connell on Q4 2016 Results - Earnings Call Tr..
01/24 Waters +2.7%; Q4 over forecasts
Advertisement
Financials ($)
Sales 2017 2 238 M
EBIT 2017 675 M
Net income 2017 550 M
Finance 2017 681 M
Yield 2017 -
P/E ratio 2017 22,72
P/E ratio 2018 20,82
EV / Sales 2017 5,29x
EV / Sales 2018 4,99x
Capitalization 12 525 M
More Financials
Chart WATERS CORPORATION
Duration : Period :
Waters Corporation Technical Analysis Chart | WAT | US9418481035 | 4-Traders
Full-screen chart
Technical analysis trends WATERS CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 156 $
Spread / Average Target -0,34%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christopher James O'Connell President, Chief Executive Officer & Director
Douglas A. Berthiaume Chairman
David A. Terricciano Senior Vice President-Global Operations
Sherry L. Buck Chief Financial Officer & Senior Vice President
Edward W. Conard Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WATERS CORPORATION16.38%12 602
THERMO FISHER SCIENTIF..12.67%62 801
DANAHER CORPORATION10.59%59 542
BOSTON SCIENTIFIC CORP..14.56%33 742
INTUITIVE SURGICAL, IN..16.19%28 581
PHILIPS-3.53%27 440
More Results